Q1 2025 Earnings Call Transcript May 5, 2025 Certara, Inc. beats earnings expectations. Reported EPS is $0.14, expectations ...

Fintel reports that on May 8, 2025, Barclays upgraded their outlook for Certara (NasdaqGS:CERT) from Equal-Weight to ...

Certara Inc (CERT) reports a robust 10% revenue growth and unveils strategic advancements, while navigating industry ...

Q1 2025 Results Conference Call May 5, 2025 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations, Gilmartin ...

Discover key Q1 2025 insights from Certara, Inc., including 10% revenue growth, biosimulation advancements, AI integration, and strategic innovations ...

Certara (CERT) delivered earnings and revenue surprises of 7.69% and 0.01%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

William Feehery; Chief Executive Officer, Director; Certara Inc. John Gallagher; Chief Financial Officer; Certar ...

Key Insights The projected fair value for Certara is US$8.98 based on 2 Stage Free Cash Flow to Equity Current ...

Certara Inc. (NASDAQ:CERT), a biosimulation company with a market capitalization of $2.06 billion, reported robust financial results for the first quarter of 2025, surpassing analyst expectations ...

Certara, Inc. reports Q1 2025 revenue of $106 million, a 10% increase, with net income of $4.7 million. Certara, Inc. reported strong financial results for the first quarter of fiscal 2025 ...

Tuesday, Certara Inc . (NASDAQ:CERT) maintained its Market Perform rating from JMP Securities following the company’s first-quarter earnings report. According to InvestingPro data, the company ...

Certara is well positioned to support the continued adoption of Biosimulation by industry to gain important insights into new therapies. We continue to work closely with our customers as they ...